Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
ABT — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

1.16

Margin Of Safety %

23

Put/Call OI Ratio

0.6

EPS Next Q Diff

0.33

EPS Last/This Y

0.37

EPS This/Next Y

0.55

Price

100.15

Target Price

121.25

Analyst Recom

1.53

Performance Q

4.48

Upside

-32.1%

Beta

0.55

Ticker: ABT




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-09-08ABT105.570.570.88236445
2026-09-09ABT105.230.570.92238094
2026-09-10ABT103.380.582.27239967
2026-09-11ABT101.970.590.95242385
2026-09-14ABT103.090.610.33241399
2026-09-15ABT102.020.610.61242676
2026-09-16ABT102.360.600.55243535
2026-09-17ABT102.230.581.51245604
2026-09-18ABT102.540.580.50248014
2026-09-21ABT102.990.650.37190585
2026-09-22ABT103.720.640.30195109
2026-09-23ABT103.530.630.32198394
2026-09-24ABT101.070.620.23206759
2026-09-25ABT101.30.611.18210322
2026-09-28ABT100.990.620.16210216
2026-09-29ABT100.960.601.07215657
2026-09-30ABT98.820.610.38219427
2026-10-01ABT96.70.610.95220875
2026-10-02ABT97.490.600.40222180
2026-10-05ABT100.130.600.34219384
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-09-08ABT105.579.22693.55.52
2026-09-09ABT105.179.22910.65.52
2026-09-10ABT103.389.22771.25.52
2026-09-11ABT101.979.22811.95.52
2026-09-14ABT103.099.23051.85.52
2026-09-15ABT102.059.22844.75.52
2026-09-16ABT102.059.22844.75.52
2026-09-17ABT102.249.22931.65.52
2026-09-18ABT102.549.22973.05.52
2026-09-21ABT102.979.22977.65.52
2026-09-22ABT103.749.23014.85.52
2026-09-23ABT103.539.22927.95.52
2026-09-24ABT101.079.22715.05.52
2026-09-25ABT101.299.22964.15.52
2026-09-28ABT100.989.22913.35.52
2026-09-29ABT100.969.22941.15.52
2026-09-30ABT98.829.22739.15.52
2026-10-01ABT96.709.22734.85.52
2026-10-02ABT97.509.22812.55.52
2026-10-05ABT100.159.23205.55.52
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-09-08ABT-3.17-1.371.19
2026-09-09ABT-3.17-1.371.19
2026-09-10ABT-3.17-1.371.19
2026-09-11ABT-3.17-1.371.29
2026-09-14ABT-3.17-1.351.29
2026-09-15ABT-3.17-1.351.29
2026-09-16ABT-3.17-1.351.29
2026-09-17ABT-3.17-1.351.29
2026-09-18ABT-3.17-1.351.29
2026-09-21ABT-3.17-1.351.29
2026-09-23ABT-3.17-1.351.29
2026-09-24ABT-3.17-1.351.29
2026-09-25ABT-3.17-1.351.16
2026-09-28ABT-3.17-1.351.16
2026-09-29ABT-3.17-1.351.16
2026-09-30ABT-3.17-1.351.16
2026-10-01ABT-3.17-1.351.16
2026-10-02ABT-3.21-1.351.16
2026-10-05ABT-3.21-1.361.16
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

1.31

Avg. EPS Est. Current Quarter

1.42

Avg. EPS Est. Next Quarter

1.64

Insider Transactions

-3.21

Institutional Transactions

-1.36

Beta

0.55

Average Sales Estimate Current Quarter

12991

Average Sales Estimate Next Quarter

13541

Fair Value

123.58

Quality Score

83

Growth Score

83

Sentiment Score

31

Actual DrawDown %

29.8

Max Drawdown 5-Year %

-39.6

Target Price

121.25

P/E

32.36

Forward P/E

16.51

PEG

1.77

P/S

3.72

P/B

3.39

P/Free Cash Flow

22.15

EPS

3.09

Average EPS Est. Cur. Y​

5.52

EPS Next Y. (Est.)

6.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.6

Relative Volume

0.93

Return on Equity vs Sector %

-15.5

Return on Equity vs Industry %

-0.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

3205.5
◆ ABT Healthcare
$100.13
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
21/25
Volume
7/15
Valuation
20/20
TP/AR
1/10
Options
5/10
RSI
40.9
Range 1M
39.7%
Sup Dist
4.3%
🚀
Momentum Growth
Ride accelerating trends
N/A
27 /100
WEAK
Momentum
2/25
Growth
10/30
Estimates
6/20
Inst/Vol
2/15
Options
7/10
EPS Yr
7.1%
EPS NY
10%
52W%
34.5%
💎
Long-Term Value
Quality companies, undervalued
37 /100
WEAK
🟡 HOLD +27.9% upside
Quality
11/30
Valuation
13/30
Growth
7/25
Stability
5/10
LT Trend
1/5
Upside
+27.9%
Quality
83
MoS
23%
ABT — P/E HistoricalMedical Devices
Abbott Laboratories
Sector: Healthcare
Industry: Medical Devices
Employees: 122000
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
ABT

Latest News

—
Caricamento notizie per ABT…
stock quote shares ABT – Abbott Laboratories Stock Price stock today
news today ABT – Abbott Laboratories stock forecast ,stock prediction 2023 2024 2025
marketwatch ABT – Abbott Laboratories yahoo finance google finance
stock history ABT – Abbott Laboratories invest stock market
stock prices ABT premarket after hours
ticker ABT fair value insiders trading